Page 23 - Vitro Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

AlloVir (NASDAQ:ALVR – Free Report) and Vitro Diagnostics (OTCMKTS:VODG – Free Report) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, profitability, analyst recommendations, institutional ownership, dividends, valuation and earnings. Earnings and Valuation This table compares AlloVir and Vitro Diagnostics’ top-line […]

Courant Market Research has released a new report titled “In-Vitro Diagnostics (IVD) Market 2023 Research,” which provides an in-depth analysis of statistical

The In Vitro Diagnostics Market demand is expected to grow at a 4.8% CAGR between 2023 and 2033. The market is expected to reach a value of US$ 129.9 billion by 2033, up from US$ 81.3 billion in 2023.The demand for improved IVD testing is being driven by advances in medical science and complex disorders. Furthermore...

.

Surmodics (NASDAQ:SRDX – Get Rating) issued an update on its FY 2023 earnings guidance on Friday morning. The company provided earnings per share (EPS) guidance of -$1.98–$1.68 for the period, compared to the consensus estimate of -$1.85. The company issued revenue guidance of $103.00 million-$106.00 million, compared to the consensus revenue estimate of $104.95 million. […]